Request Deal Involvement
Bain Capital, and Cinven, to make an offer for the 63% of STADA Arzneimittel AG's shares.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Perella Weinberg Partners
financial advisors
Evercore
legal advisors
Freshfields Bruckhaus Deringer
legal advisors
Skadden Arps Slate Meagher & Flom
financial advisors
Deutsche Bank
financial advisors
JP Morgan
financial advisors
Macquarie Group
financial advisors
UBS
financial advisors
Barclays
financial advisors
Rothschild & Co
financial advisors
Societe Generale
financial advisors
Jefferies & Company
financial advisors
Nomura
pr advisors
Camarco
legal advisors
Kirkland & Ellis
legal advisors to financial advisors
Linklaters
legal advisors to debt providers
Latham & Watkins
financial advisors
JP Morgan
financial advisors
UBS
financial advisors
Rothschild & Co
financial advisors
Barclays
financial advisors
Jefferies & Company
financial advisors
Macquarie Group
financial advisors
Societe Generale
pr advisors
FTI Consulting
legal advisors
Kirkland & Ellis
legal advisors to financial advisors
Linklaters
or
Principals
target
STADA ARZNEIMITTEL AG
bidder
BAIN CAPITAL LP
bidder
CINVEN LTD
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite